Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1778-1789
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1778
Table 1 Clinicopathological characteristics and univariate analysis of 1106 patients

n (%)
P value
Preoperative variables
Age (yr)0.202
≤ 55 436 (39)
> 55670 (61)
Sex0.098
Male 863 (78)
Female243 (22)
Viral hepatitis0.111
No viral hepatitis 185 (17)
Hepatitis B or C or B + C 921 (83)
Child Class0.964
A/B 1099 (99)
C 7 (1)
Platelet count (103/μL)0.003
< 100124 (11)
≥ 100982 (89)
Total bilirubin (mg/dL)0.032
≤ 1.3 1010 (91)
> 1.396 (9)
PT-INR0.053
≤ 1.21004 (91)
> 1.2 102 (9)
Albumin (g/dL)0.001
< 3.5 86 (8)
≥ 3.5 1020 (92)
AFP (ng/mL)0.116
< 200 785 (71)
≥ 200 321 (29)
ICG (%)< 0.0001
≤ 10 748 (68)
> 10 358 (32)
Multiplicity< 0.0001
Solitary 852 (77)
Multiple 254 (23)
Radiologic TTV (cm3)< 0.0001
mean ± SD113.06 ± 237.13
≤ 32.0645 (58)
> 32.0 461 (42)
Postoperative variables
Resection margin (cm)0.082
≤ 1.0817 (74)
> 1.0249 (23)
Liver cirrhosis0.001
No585 (53)
Yes 521 (47)
Tumor rupture0.004
No 1076 (97)
Yes 30 (3)
Edmondson-Steiner grade< 0.0001
I/II 682 (62)
III/IV 424 (38)
Capsule0.789
No192 (17)
Yes 914 (83)
Microvascular invasion< 0.0001
No786 (71)
Yes 320 (29)
Pathologic TTV (cm3)< 0.0001
mean ± SD131.59 ± 293.81
≤ 32.8 652 (59)
> 32.8 454 (41)
Table 2 Univariate and multivariate analysis of prognostic factors

UV P value
HR
95%CI
MV P value
Platelet count (103/μL)0.0031.192-1.8820.001
< 1001.498
≥ 1001
Total bilirubin (mg/dL)0.032-
≤ 1.3
> 1.3
Albumin (g/dL)0.0011.121-1.9070.005
< 3.5 1.462
≥ 3.5 1
ICG (%)< 0.00011.104-1.5070.001
≤ 10 1
> 10 1.289
Multiplicity< 0.00011.422-2.019< 0.0001
Solitary 1
Multiple 1.694
Radiologic TTV (cm3)< 0.00011.501-2.024< 0.0001
≤ 32.01
> 32.0 1.743
Table 3 Point values for risk groups according to the Cox regression model
Predictor variables
Regression coefficients (β)
Categories
Reference value (W)
Β (W-WREF)
Points = β (W-WREF)/constant B
Platelet count (103/μL)0.4039< 10000010.40392
≥ 1000000 (WREF)00
Albumin (g/dL)0.3805< 3.510.38051
≥ 3.50 (WREF)00
ICG (%)0.2544≤ 100 (WREF)00
> 1010.254411
Multiplicity0.5274Solitary0 (WREF)00
Multiple10.52742
Radiologic TTV (cm3)0.5558≤ 32.00 (WREF)00
> 32.010.55582
Table 4 Discrimination measures and hazard ratios evaluated among four scoring systems
Scoring system
CGMH
AJCC 8th edition
Tokyo
Taipei
Estimate
SE
Estimate
SE
Estimate
SE
Estimate
SE
Measures of discrimination
Harrell’s CH0.6170.010.6170.010.6130.0110.5620.01
Gonen and Heller’s CGH0.5990.0090.5860.0090.5870.015390.009
Royston & Sauerbrei’s D 0.6720.0660.5770.0650.5890.0660.2920.067
Prognostic scoring systemHR95%CI of HRP valueHR95%CI of HRP valueHR95%CI of HRP valueHR95%CI of HRP value
CGMH: Low11111
Intermediate, high1.811.50-2.19< 0.00011.351.08-1.690.0091.551.04-2.290.031.211.01-1.450.039
AJCC 8th edition:2.742.25-3.34< 0.00011.691.29-2.21< 0.0011.71.16-2.490.0071.431.08-1.880.012
IA1, IB, II, IIIA, IIIB2.081.57-2.76< 0.00012.641.76-3.96< 0.00011.791.31-2.44< 0.001
Tokyo: 01, 1, 2, 3, 4, 53.152.41-4.12< 0.00014.142.70-6.36< 0.00011.260.97-1.640.079
Taipei: 01, 1, 2, 3, 44.12.54-6.63< 0.0001
Table 5 Performance of prognostic scoring systems
Prognostic scoring systemHomogeneity
Discriminatory ability
Akaike information criterion
Likelihood ratio χ2
Linear trend χ2
CGMH106.05106.489305.48
AJCC 8th81.5394.169336.01
Tokyo93.02109.459324.52
Taipei18.7620.419396.77